Back to search

Article

Neutralizing antibody and T-cell spike targeted responses following receipt of a monovalent Omicron JN.1-adapted mRNA COVID-19 vaccine in immunosuppressed and healthy individuals

2025-05-06

Abstract excerpt

We evaluated homologous neutralizing antibody (NtAb) and T-cell responses after receipt of a JN.1-adapted mRNA vaccine in a mixed population comprising healthy controls (HC) (n=15), end-stage chronic kidney disease (CKD) patients (n=17), and allogeneic hematopoietic stem cell transplant recipients (allo-HCT) (n=13). Most participants (42/45) were SARS-CoV-2-experienced at the time of immunological testing. JN.1-sp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
04182c66-0947-5feb-a478-9c8eef77093b
DOI
10.22541/au.174653646.66883385/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutralizing antibody and T-cell spike targeted responses following receipt of a monovalent Omicron JN.1-adapted mRNA COVID-19 vaccine in immunosuppressed and healthy individualsDOI 10.22541/au.174653646.66883385/v1
Select a neighboring publication to make it the new centre.